Biogen has agreed to pay $7.3 billion to acquire Reata Pharmaceuticals — the maker of a new treatment for a rare genetic disorder. The deal is expected to close by the end of the year.
Walgreens Boots Alliance continues to expand its healthcare offerings as it aims to compete against more vertically integrated entities such as CVS Health, and it wants its next CFO to come with healthcare experience.
Of the 13 Pfizer essential drugs the United States Pharmacopeia named as the most likely to go into new or worsened shortages, all of them are already in short supply.
A Florida physician was found guilty of 14 counts of unlawfully distributing and dispensing controlled substances without a legitimate medical purpose and 5 counts of obstructing justice.
South Texas College in McAllen is the first college in the nation to offer a registered apprenticeship program for nursing, the organization said July 31.
Injectable versions of some widely used cancer drugs may be excluded from the new Medicare price negotiations until the 2030s, Reuters reported July 28.
The median year-to-date operating margin index for hospitals improved to 1.4 percent in June, according to Kaufman Hall’s latest “National Flash Hospital Report,” which is based on data from more than 1,300 hospitals.
Nashville, Tenn.-based HCA Healthcare has taken steps to secure its physician management strategy after Dallas-based Envision Healthcare filed for bankruptcy earlier this year.